Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00336271 · ClinicalTrials.gov registry record
The Effects of Coffee
A clinical trial of Healthy Subjects, sponsored by American University.
- Completed
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT00336271 is a study of Healthy Subjects that has completed, run by American University. The registered enrollment target is 50 participants, below the 128-participant average among 69 other Healthy Subjects trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00336271, a study of Healthy Subjects, has completed, sponsored by American University.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study, participants will be eligible to participate in a paid research study that will examine the effects of regular coffee drinking. The study takes approximately 2 hours total, 55 min. on 2 separate days. Participants will be asked to do computer tasks and drink only coffee provided to them during the study.
Conditions Studied
Study Locations (1)
District of Columbia
- Room 137 Asbury Building-American University - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2006-04 |
| Est. Completion | 2007-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00336271
The ClinicalTrials.gov registry entry for NCT00336271 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 128-participant average among 69 other Healthy Subjects trials with a reported enrollment target (61% lower). The listed sponsor is American University, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Subjects appearing as the primary indexed condition, and to 0 interventions.
NCT00336271 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT00336271 about?
NCT00336271 is a clinical study titled "The Effects of Coffee". In this study, participants will be eligible to participate in a paid research study that will examine the effects of regular coffee drinking. The study takes approximately 2 hours total, 55 min. on 2 separate days. Participants will be asked to do computer tasks and drink only coffee provided to th...
What is the current status of trial NCT00336271?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2006-04. Estimated completion is 2007-03.
What conditions does trial NCT00336271 study?
This clinical trial studies the following conditions: Healthy Subjects.
Who is sponsoring clinical trial NCT00336271?
This trial is sponsored by American University, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00336271 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Subjects
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
RECRUITING
-
Phase I Study of ICP-332 in Healthy Subjects
RECRUITING · Phase 1
-
Radiocaine Safety Study In Healthy Human Subjects
RECRUITING · Early Phase 1
-
Optimizing Ultrasound-induced Anti-inflammation in Human Subjects
RECRUITING · NA
-
Single-tracer Multiparametric PET Imaging
RECRUITING · Early Phase 1
-
A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.